About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The search for quality and innovation has always been an inherent part of the activity of the Stroke Research Group and represents the common thread that leads us to excellence and continuous improvement.
In recent years, the Stroke Research Group has established itself as a leader in the management, recruitment and international coordination of multicenter clinical trials, as well as in the development of patents for new thrombectomy devices and the creation of new technological solutions and digital platforms to improve the diagnosis, treatment and follow-up of stroke patients. Robust strategic alliances have also been consolidated with public and private entities that ensure the viability and scalability of the research projects initiated in our group.
The Stroke Research Group is made up of a transversal and multidisciplinary team that shares a common idea: to contribute from its area of knowledge to the care and management of stroke through the effective transfer of knowledge and the complementarity of the processes of clinical research.
IP: Maria Mar Hernandez Guillamon Collaborators: Marcel Lamana Vallverdu, Anna Bonaterra Pastra, Jessica Camacho Soriano, Olga Maisterra Santos, Olalla Pancorbo Rosal Funding agency: Instituto de Salud Carlos III Funding: 169400 Reference: PI20/00465 Duration: 01/01/2021 - 30/06/2025
IP: Marta Aurora Rubiera Del Fueyo Collaborators: Estefania Montiel, Marc Rodrigo Gisbert Funding agency: Instituto de Salud Carlos III Funding: 90750 Reference: PI20/01768 Duration: 01/01/2021 - 30/06/2025
IP: David Rodriguez Luna Collaborators: Noelia Rodríguez Villatoro, Olalla Pancorbo Rosal Funding agency: Instituto de Salud Carlos III Funding: 38720 Reference: PI20/00834 Duration: 01/01/2021 - 30/06/2025
IP: Marta Olive Gadea Collaborators: Marc Ribó Jacobi Funding agency: Instituto de Salud Carlos III Funding: 107690 Reference: PI21/01967 Duration: 01/01/2022 - 31/12/2024
PMID: 37830330 Journal: Journal of the American Heart Association Year: 2023 Reference: J Am Heart Assoc. 2023 Oct 13:e029965. doi: 10.1161/JAHA.123.029965. Impact factor: Publication type: Paper in international publication Authors: Arnold, Marcel; Bilgin, Cem; Castano, Oscar; Dequatre-Ponchelle, Nelly; Dobrocky, Tomas; Fischer, Urs; Goeldlin, Martina B; Gralla, Jan; Hutar, Jared; Jung, Simon et al. DOI: 10.1161/JAHA.123.029965
PMID: 37841069 Journal: Brain communications Year: 2023 Reference: Brain Commun. 2023 Oct 4;5(5):fcad255. doi: 10.1093/braincomms/fcad255. eCollection 2023. Impact factor: Publication type: Paper in international publication Authors: Barkhof, Frederik; Brownlee, Wallace; Castano, Carlos; Chard, Declan; Chung, Karen; Ciccarelli, Olga; Dominguez, Carlos; Gandini Wheeler-Kingshott, Claudia A M; Gramegna, Laura Ludovica; Haider, Lukas et al. DOI: 10.1093/braincomms/fcad255
PMID: 37034728 Journal: Year: 2023 Reference: medRxiv. 2023 Sep 18:2023.03.27.23287713. doi: 10.1101/2023.03.27.23287713. Preprint. Impact factor: Publication type: Other (letters to the editor, abstracts, corrigendum, etc.) Authors: Abraira, L; Ballve, A; Batzler, Anthony; Bianchi, Sevim B; Biernacka, Joanna M; Campos, D; Coombes, Brandon J; Cox, Nancy J; Davis, Lea K; Ehinmowo, Michael et al. DOI: 10.1101/2023.03.27.23287713
PMID: 37893235 Journal: Biomedicines Year: 2023 Reference: Biomedicines. 2023 Oct 22;11(10):2861. doi: 10.3390/biomedicines11102861. Impact factor: Publication type: Paper in international publication Authors: Abraham, Michael; Alonso Luengo, Olga; Arto Millan, Luis Maria; Belanger Quintana, Amaya; Camprodon Gomez, Maria; Correcher Medina, Patricia; Dawod, Giana; Del Castillo, Francisco J; Diez Langhetee, Lydia; Divani, Afshin A et al. DOI: 10.3390/biomedicines11102861
PMID: 33858973 Journal: Journal of NeuroInterventional Surgery Year: 2022 Reference: J Neurointerv Surg. 2022 Jan;14(1). pii: neurintsurg-2021-017487. doi: 10.1136/neurintsurg-2021-017487. Epub 2021 Apr 15. Impact factor: 5.836 Publication type: Paper in international publication Authors: de Dios Lascuevas, Marta, Canals, Pere, Engel, Elisabeth, Ribo, Marc, Tomasello, Alejandro, Castano, Oscar, Li, Jiahui et al. DOI: 10.1136/neurintsurg-2021-017487
The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.
Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.
The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.
